These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36111370)

  • 21. [A clinical study of 26 cases of cryptococcal meningitis].
    Liu Z; Wang A; Li T; Qin S; Sheng R
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):541-3. PubMed ID: 12421503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
    Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
    J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
    Miot J; Leong T; Takuva S; Parrish A; Dawood H
    BMC Health Serv Res; 2021 Apr; 21(1):305. PubMed ID: 33823842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
    Larsen RA; Leal MA; Chan LS
    Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
    Shapiro AE; Tenforde MW; Chiller TM; Ford N; Rajasingham R
    HIV Med; 2023 Apr; 24(4):507-512. PubMed ID: 36123803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
    Boulware DR; Atukunda M; Kagimu E; Musubire AK; Akampurira A; Tugume L; Ssebambulidde K; Kasibante J; Nsangi L; Mugabi T; Gakuru J; Kimuda S; Kasozi D; Namombwe S; Turyasingura I; Rutakingirwa MK; Mpoza E; Kigozi E; Muzoora C; Ellis J; Skipper CP; Matkovits T; Williamson PR; Williams DA; Fieberg A; Hullsiek KH; Abassi M; Dai B; Meya DB
    Clin Infect Dis; 2023 Dec; 77(12):1659-1667. PubMed ID: 37606364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
    Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
    Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.
    Beyene T; Zewde AG; Balcha A; Hirpo B; Yitbarik T; Gebissa T; Rajasingham R; Boulware DR
    Clin Infect Dis; 2017 Nov; 65(12):2126-2129. PubMed ID: 29020172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
    Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
    Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
    Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
    Temfack E; Boyer-Chammard T; Lawrence D; Delliere S; Loyse A; Lanternier F; Alanio A; Lortholary O
    Curr Neurol Neurosci Rep; 2019 Oct; 19(10):81. PubMed ID: 31673881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-course amphotericin B in addition to sertraline and fluconazole for treatment of HIV-associated cryptococcal meningitis in rural Tanzania.
    Katende A; Mbwanji G; Faini D; Nyuri A; Kalinjuma AV; Mnzava D; Hullsiek KH; Rhein J; Weisser M; Meya DB; Boulware DR; Letang E;
    Mycoses; 2019 Dec; 62(12):1127-1132. PubMed ID: 31461550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients.
    Manosuthi W; Chetchotisakd P; Nolen TL; Wallace D; Sungkanuparph S; Anekthananon T; Supparatpinyo K; Pappas PG; Larsen RA; Filler SG; Andes D;
    HIV Med; 2010 Apr; 11(4):276-81. PubMed ID: 20002501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphotericin B plus fluorocytosine combined with voriconazole for the treatment of non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective study.
    Liu J; Liu J; Su X; Yang L; Wang Y; Wang A; Xu X; Li M; Jiang Y; Peng F
    BMC Neurol; 2022 Jul; 22(1):274. PubMed ID: 35869441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.